An artist's rendering of the AGM-183A Air-Launched Rapid Response Weapon. The US Air Force has decided to delay making a production decision after a trio of failed booster flight tests in 2021. (Lockheed Martin )

US Air Force (USAF) leaders are postponing making an AGM-183A Air-Launched Rapid Response Weapon (ARRW) production decision following three failed booster flight tests with the hypersonic weapon prototype in 2021, the service told Janes .

“The ARRW procurement plan has not changed from the fiscal year (FY) 2022 president's budget request. However, the production contract award has been delayed as the team resolves the current launch abort,” a USAF spokesperson wrote in a 19 January statement. “The production decision remains event-driven and will occur after operational utility is demonstrated with a successful all-up-round test flight and a successful production readiness review.”

An artist's rendering of the AGM-183A Air-Launched Rapid Response Weapon. The US Air Force has decided to delay making a production decision after a trio of failed booster flight tests in 2021. (Lockheed Martin )

US Air Force (USAF) leaders are postponing making an AGM-183A Air-Launched Rapid Response Weapon (ARRW) production decision following three failed booster flight tests with the hypersonic weapon prototype in 2021, the service told Janes .

“The ARRW procurement plan has not changed from the fiscal year (FY) 2022 president's budget request. However, the production contract award has been delayed as the team resolves the current launch abort,” a USAF spokesperson wrote in a 19 January statement. “The production decision remains event-driven and will occur after operational utility is demonstrated with a successful all-up-round test flight and a successful production readiness review.”

An artist's rendering of the AGM-183A Air-Launched Rapid Response Weapon. The US Air Force has decided to delay making a production decision after a trio of failed booster flight tests in 2021. (Lockheed Martin )

US Air Force (USAF) leaders are postponing making an AGM-183A Air-Launched Rapid Response Weapon (ARRW) production decision following three failed booster flight tests with the hypersonic weapon prototype in 2021, the service told Janes .

“The ARRW procurement plan has not changed from the fiscal year (FY) 2022 president's budget request. However, the production contract award has been delayed as the team resolves the current launch abort,” a USAF spokesperson wrote in a 19 January statement. “The production decision remains event-driven and will occur after operational utility is demonstrated with a successful all-up-round test flight and a successful production readiness review.”

An artist's rendering of the AGM-183A Air-Launched Rapid Response Weapon. The US Air Force has decided to delay making a production decision after a trio of failed booster flight tests in 2021. (Lockheed Martin )

US Air Force (USAF) leaders are postponing making an AGM-183A Air-Launched Rapid Response Weapon (ARRW) production decision following three failed booster flight tests with the hypersonic weapon prototype in 2021, the service told Janes .

“The ARRW procurement plan has not changed from the fiscal year (FY) 2022 president's budget request. However, the production contract award has been delayed as the team resolves the current launch abort,” a USAF spokesperson wrote in a 19 January statement. “The production decision remains event-driven and will occur after operational utility is demonstrated with a successful all-up-round test flight and a successful production readiness review.”

An artist's rendering of the AGM-183A Air-Launched Rapid Response Weapon. The US Air Force has decided to delay making a production decision after a trio of failed booster flight tests in 2021. (Lockheed Martin )

US Air Force (USAF) leaders are postponing making an AGM-183A Air-Launched Rapid Response Weapon (ARRW) production decision following three failed booster flight tests with the hypersonic weapon prototype in 2021, the service told Janes .

“The ARRW procurement plan has not changed from the fiscal year (FY) 2022 president's budget request. However, the production contract award has been delayed as the team resolves the current launch abort,” a USAF spokesperson wrote in a 19 January statement. “The production decision remains event-driven and will occur after operational utility is demonstrated with a successful all-up-round test flight and a successful production readiness review.”

An artist's rendering of the AGM-183A Air-Launched Rapid Response Weapon. The US Air Force has decided to delay making a production decision after a trio of failed booster flight tests in 2021. (Lockheed Martin )

US Air Force (USAF) leaders are postponing making an AGM-183A Air-Launched Rapid Response Weapon (ARRW) production decision following three failed booster flight tests with the hypersonic weapon prototype in 2021, the service told Janes .

“The ARRW procurement plan has not changed from the fiscal year (FY) 2022 president's budget request. However, the production contract award has been delayed as the team resolves the current launch abort,” a USAF spokesperson wrote in a 19 January statement. “The production decision remains event-driven and will occur after operational utility is demonstrated with a successful all-up-round test flight and a successful production readiness review.”